Atlas Trials

Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019)

Clinical trial NCT00393705 · COMPLETED

Trial details

NCT number
NCT00393705
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2006-10-01
Primary completion
2009-03-01
Enrollment
302

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.